Viewing Study NCT00362011



Ignite Creation Date: 2024-05-05 @ 5:00 PM
Last Modification Date: 2024-10-26 @ 9:26 AM
Study NCT ID: NCT00362011
Status: COMPLETED
Last Update Posted: 2006-08-09
First Post: 2006-08-08

Brief Title: Effect of Chia Seeds Salvia Hispanica L on Glucose Control in Patients With Type 2 Diabetes
Sponsor: Unity Health Toronto
Organization: Unity Health Toronto

Study Overview

Official Title: Effect of Chia Seeds Salvia Hispanica L on Glucose Control in Patients With Type 2 Diabetes
Status: COMPLETED
Status Verified Date: 2001-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to determine whether the addition of Salvia hispanica L Alba Salba to the conventional treatment for diabetes is associated with improvement in major and emerging cardiovascular risk factors in people with type 2 diabetes
Detailed Description: Cohort studies have linked consumption of whole grain with a reduction in the risk of developing diabetes and heart disease Grain of the plant Salvia hispanica alba Salba contain a high concentration of ω-3 fatty acids in addition to being a rich source of vegetable protein fiber calcium and antioxidants which have cardiovascular protective effect To address the paucity of randomized well-controlled clinical studies supporting the long-term cardioprotective benefits of whole grain we investigated the effects of a novel grain Salba in type 2 diabetes

Comparisons Participants on a conventional diabetes diet 50 carbohydrate 20 protein 30 fat receive either addition of Salba or matched control supplement for 12 weeks separated by a 4-week washout period

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None